Abstract
Characterization of Prescription Patterns and Estimated Costs for Use of Oxygen Concentrators for Home Oxygen Therapy in the US
Highlights
Home oxygen is a critical component of therapy for patients with acute and chronic lung disease
A map of the US showing the estimated cost of running a regular-oxygen-flow 350-watt concentrator continuously for 1 year in each state is displayed in the Figure
States varied significantly in the number of oxygen concentrators prescribed, ranging from 0.51% to 8.20% of the local Medicare population
Summary
Home oxygen is a critical component of therapy for patients with acute and chronic lung disease. There are several technologies available to deliver home oxygen, including compressed gas cylinders, liquid oxygen technologies, and oxygen concentrators, oxygen concentrators remain highly used due to their ease of use and no need for refills. The cost of oxygen concentrators and other durable medical goods is covered by Medicare, the cost of operating these devices is not. Despite the high prevalence of oxygen concentrators and expected increase in use due to the COVID-19 pandemic, minimal information is available about the financial burden of these devices and potential impact on device adherence.[1,2] In this study, we sought to characterize prescription patterns for oxygen concentrators in the Medicare population as well as local energy costs for these devices.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
